Skip to main content
    N

    Nano X Imaging Ltd (NNOX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.29
    -0.03 (-10.24%)

    Market Cap: $25.22M

    Last updated: Nov 17, 2026 at 4:28 PM ET

    Nano X Imaging Ltd (NNOX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Nano X Imaging (NNOX) has a market cap of $25.22M. It kept -747.20% of revenue as net income over the last 12 months. Its share count is up 9.42% from a year earlier.

    Total Valuation

    Market Cap$25.22M
    Latest price (Nov 17, 2026)$0.29

    Key Dates

    The next earnings report is expected on Nov 25, 2026, covering the quarter ending Sep 30, 2026.

    Next Earnings DateNov 25, 2026 (expected)
    Last Earnings DateJul 20, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.45% in the quarter ended Jun 30, 2026 and grew 9.80% a year over 2 years.

    Shares Outstanding69.93M
    Shares Change (YoY)+9.42%
    Shares Change (QoQ)+0.45%
    Share Count Growth (2Y CAGR)+9.80%

    Valuation Ratios

    Sales and book value multiples are 1.3x and 0.3x. Its year-end P/S ranged from 14.0x to 344.9x from 2021 to 2025.

    P/S Ratio1.3x
    Forward P/S1.1x
    P/B Ratio0.3x
    P/TBV Ratio0.3x

    Valuation history and multiples

    Price Statistics

    The stock is down 90.32% over 52 weeks and trades 43.14% below its 50-day average.

    Beta (1Y)1.21
    52-Week Change-90.32%
    1-Month Change-29.88%
    3-Month Change-69.09%
    6-Month Change-83.38%
    5-Year Change-98.54%
    Total Return (1Y)-90.32%
    Total Return (3Y CAGR)-64.70%
    Total Return (5Y CAGR)-56.78%
    Max Drawdown (1Y)-94.87%
    Max Drawdown (3Y)-98.20%
    Sharpe Ratio (1Y)-2.10
    Correlation with SPY (1Y)0.14
    50-Day Average$0.51
    200-Day Average$1.43
    52-Week Range$0.21 to $4.71
    RSI (14 Days)36.3
    Average Volume (20 Days)5.98M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.84x current liabilities.

    Current Ratio2.84x
    Quick Ratio2.59x

    Returns and Efficiency

    Return on equity is -161.19% over the last 12 months, against a 5-year average of -36.56%.

    Return on Equity (ROE)-161.19%
    Return on Assets (ROA)-128.10%
    Return on Capital Employed (ROCE)-130.91%
    ROE (5Y Average)-36.56%
    ROA (5Y Average)-31.60%
    ROIC (5Y Average)-31.41%
    Asset Turnover0.11x
    Inventory Turnover20.56x
    Receivables Turnover7.63x
    Cash Conversion Cycle54 days

    Scores

    NNOX has an Altman Z-Score of -10.48, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score-10.48
    Altman Z ZoneDistress
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of $15.63M over the last 12 months is up 31.52% from the 12 months before.

    Revenue$15.63M
    Revenue Growth (YoY)+31.52%
    Gross Profit-$53.17M
    Operating Income-$101.00M
    Pretax Income-$118.57M
    Net Income-$116.81M
    EBITDA-$89.98M
    EBIT-$101.42M
    Reported EPS (TTM)-$1.31

    Trailing 12 months through Jun 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 79.47% of the $91.19M in total assets.

    Cash and Equivalents$31.02M
    Working Capital$25.27M
    Shareholder Equity$72.47M
    Book Value Per Share$1.04
    Tangible Book Value$57.99M
    Tangible Book Per Share$0.83
    Total Assets$91.19M
    Total Liabilities$18.72M

    Balance sheet as of Jun 30, 2026.

    Full balance sheet

    Cash Flow

    After $5.49M of capital spending, operating cash flow left -$53.28M of free cash flow.

    Operating Cash Flow-$47.79M
    Capital Expenditures$5.49M
    Free Cash Flow-$53.28M
    FCF Per Share-$0.68
    Depreciation and Amortization$11.44M

    Trailing 12 months through Jun 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -646.09%.

    Gross Margin-340.09%
    Operating Margin-646.09%
    Pretax Margin-758.47%
    Net Margin-747.20%
    EBITDA Margin-575.56%
    EBIT Margin-648.76%
    FCF Margin-340.83%
    Gross Margin (5Y Average)-90.99%

    Growth

    Revenue grew 14.93% a year over 3 years.

    Revenue Growth (3Y CAGR)+14.93%
    Book Value Per Share Growth (2Y CAGR)-21.54%
    Tangible Book Per Share Growth (2Y CAGR)-22.78%

    Revenue and profit by year

    Dividends and Yields

    NNOX does not pay a dividend. Its free cash flow yield is -265.02%.

    FCF Yield-265.02%
    Shareholder Yield0.00%

    Peer Position

    Against 11 similar companies, NNOX has the 7th highest P/S.

    P/S Ratio1.3x vs 2.2x median
    Revenue Growth (Trailing 4 Quarters, YoY)+31.52% vs +8.41% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 78.43% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+78.43%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About NNOX

    What is NNOX's market cap?

    Nano X Imaging has a market cap of $25.22M.

    How many shares of NNOX are outstanding?

    Nano X Imaging has 69.93M shares outstanding. The count is up 9.42% from a year earlier.

    Does NNOX pay a dividend?

    No. Nano X Imaging does not pay a dividend.